Prostate Cancer - Results from #23340

Model-based cost-effectiveness analyses for prostate cancer chemoprevention: A review and summary of challenges - Abstract April 30, 2013

Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen April 30, 2013

Lymphocele after extraperitoneal robot-assisted radical prostatectomy: A propensity score-matching study - Abstract April 30, 2013

Lower baseline prostate-specific antigen (PSA) is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial April 30, 2013

Novel chemotherapies in development for management of castration-resistant prostate cancer - Abstract April 29, 2013

Interview-based versus questionnaire-based quality of life outcomes before and after prostatectomy - Abstract April 29, 2013

Longitudinal observational cohort study about detrusor underactivity as a risk factor for bladder neck contracture after retropubic radical prostatectomy: Preliminary results - Abstract April 29, 2013

Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: Results from a baseline analysis in the Canary Prostate Active Surveillance Study - Abstract April 29, 2013

Embracing life after prostate cancer. A male perspective on treatment and rehabilitation - Abstract April 29, 2013

Castration-resistant prostate cancer: Novel therapeutics pre- or post-taxane administration - Abstract April 29, 2013

Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostat April 29, 2013

Prostate cancer prevention: Strategies for agent development - Abstract April 29, 2013

Men with prostate cancer make positive dietary changes following diagnosis and treatment - Abstract April 29, 2013

Lower baseline prostate-specific antigen Is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial - Abstract April 29, 2013

Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy - Abstract April 26, 2013

Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial - Abstract April 26, 2013

Future perspectives for diagnostic imaging in urology: From anatomic and functional to molecular imaging - Abstract April 26, 2013

Extended pelvic lymph node dissection in prostate cancer: A 20-year audit in a single center - Abstract April 26, 2013

Neoadjuvant chemotherapy prior to radical prostatectomy for patients with high-risk prostate cancer: A systematic review - Abstract April 26, 2013

Early versus deferred androgen suppression therapy for patients with lymph node-positive prostate cancer after local therapy with curative intent: A systematic review - Abstract April 26, 2013

Page 1168 of 1436